+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cell-Free RNA Isolation and Extraction Kits Market - A Global and Regional Analysis: Focus on Application, End User, and Region - Analysis and Forecast, 2022-2032

  • PDF Icon

    Report

  • 132 Pages
  • August 2022
  • Region: Global
  • BIS Research
  • ID: 5651332
10% Free customization

Increasing Number of Cases with Prenatal Complications

10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

The global cell-free RNA isolation and extraction kits market is projected to reach $140.7 million by 2032 from $30.2 million in 2021, growing at a CAGR of 14.98% during the forecast period 2022-2032. The growth in the cell-free RNA isolation and extraction kits market is expected to be driven by an increasing number of kits and a rising number of open-source free sequencing platform providers offering cell-free RNA analysis.

Market Lifecycle Stage

The cell-free RNA isolation and extraction kits market is a well-developed market with an integral part of medical decision-making -aid in acquiring information for a wide range of treatment dissemination, accentuating their criticality in healthcare. The cell-free RNA has a critical role in the precision medicine approach, as it ensures the safe and effective application of targeted therapeutics. Most of the players in the global cell-free RNA isolation and extraction kits market offer products encompassing the kits.

Increasing investments in the R&D for cell-free RNA isolation and extraction is one of the major opportunities in the global cell-free RNA isolation and extraction kits market. Several biotechnology and pharmaceutical companies are working collaboratively to adopt cell-free RNA isolation and extraction in the field of oncology, prenatal screening, and metabolic disorders.

Impact

  • The presence of major products of cell-free RNA isolation and extraction kits in regions such as North America and APAC has a major impact on the market. For instance, QIAGEN N.V. provides cell-free RNA isolation and extraction kits.
  • Companies such as Zinexts Life Science Corp. and JBS Science, Inc. enter into a technology commercialization cooperation agreement to allow Zinexts to manufacture and sell JBS nucleic separation kits, including cfDNA and RNA isolation kits. This license agreement will make it easier to access JBS NA Zinexts's JBS NA isolation equipment as well as their isolation automation systems The presence of these companies has a positive impact on the market growth.

Impact of COVID-19

The current global cell-free RNA isolation and extraction kits market study comprises cell-free RNA isolation and extraction kits that are used to extract and isolate cell-free RNA form samples collected from patients and preserve cell-free RNA for further downstream analysis to retrieve actionable information from it. Since the market is primarily dominated by the manufacturers of cell-free RNA isolation and extraction kits, the pandemic had a negative impact on the growth of revenue generated from the market. Players in the cell-free RNA isolation and extraction kits market reported a decline in revenues during the initial phase of the pandemic. The decline was primarily attributed to the lockdown in the regions that disrupted the supply chain, thereby hampering the cancer diagnostic testing. Additionally, a halt in research and development activities pertaining to cell-free RNA for oncology, prenatal screening, and metabolic disorders market also led to a decline in revenue. Moreover, in order to curb the spread of the SARS-CoV-2 virus, and contain the spread of the virus, demand for COVID-19 tests and services that detects the virus in less time increased, which led to the shift in focus of the manufacturers for developing and manufacturing testing kits and services for the detection of SARS-CoV-2 virus.

Market Segmentation

by Application

  • Oncology
  • Prenatal Screening (Preeclampsia)
  • Metabolic Disorders

The oncology segment accounted for the largest share of 79.85% in the global cell-free RNA isolation and extraction kits market in 2021.

by End User

  • Hospitals
  • Academic Research Institutions and Laboratories
  • Pharmaceutical and Biotechnology Companies
  • Diagnostic Laboratories

The academic research institutions and laboratories segment accounted for the largest share of 63.13% in the global cell-free RNA isolation and extraction kits market in FY2021.

by Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Rest-of-the-World

North America cell-free RNA isolation and extraction market dominated the global cell-free RNA isolation and extraction kits market and is expected to maintain its dominance over other regions throughout the forecast period 2022-2032.

Recent Developments in Global Cell-Free RNA Isolation and Extraction Kits Market

  • In February 2022, Zinexts Life Science Corp. and JBS Science, Inc. enter into a technology commercialization cooperation agreement to allow Zinexts to manufacture and sell JBS nucleic separation kits, including cfDNA and RNA isolation kits. This license agreement will make it easier to access JBS NA Zinexts's JBS NA isolation equipment as well as their isolation automation systems.
  • In February 2019, Norgen Biotek Corp. introduced the cf-DNA / cf-RNA Preservative Tubes for long-term storage of blood. These are more suitable blood collection tubes (BCTs) as compared to other competitor’s blood collection tubes (BCTs) in the cell-free RNA market. This is the only product that keeps both cf-DNA and cf-RNA in the same tube for 30 days, allowing researchers to examine both genomics and transcriptomics.

Demand - Drivers and Limitations

Following are the demand drivers for the Global Cell-Free RNA Isolation and Extraction Kits Market:

  • Increasing Incidence of Cancer
  • Increasing Number of Cases with Prenatal Complications
  • Advancement in the RNA Sequencing Technology

The market is expected to face some limitations too due to the following challenges:

  • Lack of Skilled Professionals and Awareness Related to Cell-Free RNA Methods
  • Ethical, Legal, and Social Issues Associated with Prenatal Screening

How Can This Report Add Value to an Organization?

Product/Innovation Strategy: Major manufacturers of the global cell-free RNA isolation and extraction kits market, are actively involved in undertaking significant business strategies to translate success in research and development into the commercial clinical setting.

Growth/Marketing Strategy: Owing to increase in research activities pertaining to cell-free RNA for various areas of application, including cancer, prenatal screening, and metabolic disorders cell-free RNA isolation and extraction market have gained momentum. Awareness among patient population about non-invasive and minimally invasive methods for the detection of a disease is expected to provide opportunity for the cell-free RNA isolation and extraction kits market.

Competitive Strategy: Key players in the global cell-free RNA isolation and extraction kits market analyzed and profiled in the study have been involved as the cell-free RNA isolation and extraction kits -based product manufacturers that provide kits. Moreover, a detailed competitive benchmarking of the players operating in the global cell-free RNA isolation and extraction kits market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.

The leading top segment players include cell-free RNA isolation and extraction kits manufacture in year 2021 that caters to different area of application that includes oncology, prenatal screening, and metabolic disorders.

Some of the prominent names established in this market are:

  • Aline Biosciences
  • Apostle Sciences
  • Danagen-Bioted, S.L.
  • F. Hoffmann-La Roche Ltd.
  • JBS Science Inc.
  • Norgen Biotek Corp.
  • PerkinElmer, Inc.
  • Promega Corporation
  • QIAGEN N.V.
  • Streck, Inc.
  • Thermo Fisher Scientific Inc.
  • Takara Bio Inc.
  • Zymo Research Corporation
Frequently Asked Questions about the Global Cell-Free RNA Isolation and Extraction Kits Market

What is the estimated value of the Global Cell-Free RNA Isolation and Extraction Kits Market?

The Global Cell-Free RNA Isolation and Extraction Kits Market was estimated to be valued at $34.8 Million in 2022.

What is the growth rate of the Global Cell-Free RNA Isolation and Extraction Kits Market?

The growth rate of the Global Cell-Free RNA Isolation and Extraction Kits Market is 15.0%, with an estimated value of $140.7 Million by 2032.

What is the forecasted size of the Global Cell-Free RNA Isolation and Extraction Kits Market?

The Global Cell-Free RNA Isolation and Extraction Kits Market is estimated to be worth $140.7 Million by 2032.

Who are the key companies in the Global Cell-Free RNA Isolation and Extraction Kits Market?

Key companies in the Global Cell-Free RNA Isolation and Extraction Kits Market include Aline Biosciences, Apostle Sciences, Danagen, Bioted, S.L., F. Hoffmann, La Roche Ltd., JBS Science Inc., Norgen Biotek Corp. and Promega Corporation.

Table of Contents

1 Markets
1.1 Product Definition
1.1.1 Inclusion and Exclusion Criteria
1.2 Market Scope
1.2.1 Scope of the Study
1.2.2 Key Questions Answered in the Report
1.3 Research Methodology
1.3.1 Global cell-free RNA isolation and extraction kits market: Research Methodology
1.3.2 Data Sources
1.3.2.1 Primary Data Sources
1.3.2.2 Secondary Data Sources
1.3.3 Market Estimation Model
1.3.4 Criteria for Company Profiling
1.4 Market Overview
1.4.1 Introduction: Cell-Free RNA
1.4.2 Emergence of Cell-Free RNA
1.4.3 Spin Column-Based Technology
1.4.4 Magnetic Bead-Based Technology
1.4.5 Market Size and Growth Potential, $Million, 2021-2032
1.5 Patent Landscape
1.5.1 Patent Filing Trend
1.5.2 Patent Analysis (by Year)
1.5.3 Patent Analysis (by Country)
1.5.4 Patent Analysis (by Region)

2 Industry Analysis
2.1 Overview
2.2 Regulatory Framework in the U.S.
2.2.1 FDA Regulations
2.3 Regulatory Framework in the European Union (EU)
2.4 Regulatory Framework in Asia-Pacific
2.4.1 China
2.4.2 Japan

3 Market Dynamics
3.1 Market Dynamics
3.1.1 Overview
3.2 Impact Analysis
3.3 Market Drivers
3.3.1 Increasing Incidence of Cancer
3.3.2 Increasing Number of Cases with Prenatal Complications
3.3.3 Advancement in the RNA Sequencing Technology
3.4 Market Restraints
3.4.1 Lack of Skilled Professionals and Awareness Related to Cell-Free RNA Methods
3.4.2 Ethical, Legal, and Social Issues Associated with Prenatal Screening
3.5 Market Opportunities
3.5.1 Growth in Emerging Nations
3.5.2 Rising Funding Activities for Cell-Free RNA Biomarkers

4 Competitive Landscape
4.1 Overview
4.1.1 Corporate Strategies
4.1.1.1 Synergistic Activities
4.1.2 Business Strategies
4.1.2.1 Product Launches
4.2 Market Share Analysis
4.3 Growth-Share Analysis (by Company)

5 Application, $Million, 2021-2032
5.1 Overview
5.2 Oncology
5.3 Prenatal Screening (Preeclampsia)
5.4 Metabolic Disorders

6 End Users, $Million, 2021-2032
6.1 Overview
6.2 Academic Research Institutions and Laboratories
6.3 Hospitals
6.4 Pharmaceutical and Biotechnology Companies
6.5 Diagnostic Laboratories

7 Region, $Million, 2021-2032
7.1 Overview
7.2 North America
7.3 Europe
7.4 Asia-Pacific (APAC)
7.5 Latin America
7.6 Rest-of-the-World

8 Company Profiles
8.1 Overview
8.2 Aline Biosciences
8.2.1 Company Overview
8.2.2 Role of Aline Biosciences in the Global Cell-Free RNA Isolation and Extraction Kits Market
8.2.3 Key Competitors of the Company
8.2.4 Analyst Perspective
8.3 Apostle Sciences
8.3.1 Company Overview
8.3.2 Role of Apostle Sciences in the Global Cell-Free RNA Isolation and Extraction Kits Market
8.3.3 Key Competitors of the Company
8.3.4 Analyst Perspective
8.4 Danagen-Bioted, S.L.
8.4.1 Company Overview
8.4.2 Role of Danagen-Bioted, S.L. in the Global Cell-Free RNA Isolation and Extraction Kits Market
8.4.3 Key Competitors of the Company
8.4.4 Analyst Perspective
8.5 F. Hoffmann-La Roche Ltd.
8.5.1 Company Overview
8.5.2 Role of F. Hoffmann-La Roche Ltd. in the Global Cell-Free RNA Isolation and Extraction Kits Market
8.5.3 Key Customers of the Company
8.5.4 Key Competitors of the Company
8.5.5 Financials
8.5.6 Analyst Perspective
8.6 JBS Science Inc.
8.6.1 Company Overview
8.6.2 Role of JBS Science Inc. in the Global Cell-Free RNA Isolation and Extraction Kits Market
8.6.3 Key Competitors of the Company
8.6.4 Corporate Strategies
8.6.4.1 Synergistic Activities
8.6.4.1.1 Agreement
8.6.5 Analyst Perspective
8.7 Norgen Biotek Corp.
8.7.1 Company Overview
8.7.2 Role of Norgen Biotek Corp. in the Global Cell-Free RNA Isolation and Extraction Kits Market
8.7.3 Key Customers of the Company
8.7.4 Key Competitors of the Company
8.7.5 Business Strategies
8.7.5.1 Product Launch
8.7.6 Analyst Perspective
8.8 PerkinElmer, Inc.
8.8.1 Company Overview
8.8.2 Role of PerkinElmer, Inc. in the Global Cell-Free RNA Isolation and Extraction Kits Market
8.8.3 Key Customers of the Company
8.8.4 Key Competitors of the Company
8.8.5 Financials
8.8.6 Key Insights about the Financial Health of the Company
8.8.7 Analyst Perspective
8.9 Promega Corporation
8.9.1 Company Overview
8.9.2 Role of Promega Corporation in the Global Cell-Free RNA Isolation and Extraction Kits Market
8.9.3 Key Competitors of the Company
8.9.4 Business Strategies
8.9.4.1 Product Launch
8.9.5 Analyst Perspective
8.1 QIAGEN N.V.
8.10.1 Company Overview
8.10.2 Role of QIAGEN N.V. in the Global Cell-Free RNA Isolation and Extraction Kits Market
8.10.3 Key Customers of the Company
8.10.4 Key Competitors of the Company
8.10.5 Financials
8.10.6 Key Insights About the Financial Health of the Company
8.10.7 Business Strategies
8.10.7.1 Product Launch
8.10.8 Analyst Perspective
8.11 Streck, Inc.
8.11.1 Company Overview
8.11.2 Role of Streck, Inc. in the Global Cell-Free RNA Isolation and Extraction Kits Market
8.11.3 Key Customers of the Company
8.11.4 Key Competitors of the Company
8.11.5 Business Strategies
8.11.5.1 Product Launch
8.11.6 Analyst Perspective
8.12 Thermo Fisher Scientific Inc.
8.12.1 Company Overview
8.12.2 Role of Thermo Fisher Scientific Inc. in the Global Cell-Free RNA Isolation and Extraction Kits Market
8.12.3 Key Customers of the Company
8.12.4 Key Competitors of the Company
8.12.5 Financials
8.12.6 Key Insights About the Financial Health of the Company
8.12.7 Analyst Perspective
8.13 Takara Bio Inc.
8.13.1 Company Overview
8.13.2 Role of Takara Bio Inc. in the Global Cell-Free RNA Isolation and Extraction Kits Market
8.13.3 Key Customers of the Company
8.13.4 Key Competitors of the Company
8.13.5 Financials
8.13.6 Analyst Perspective
8.14 Zymo Research Corporation
8.14.1 Company Overview
8.14.2 Role of Zymo Research Corporation in the Global Cell-Free RNA Isolation and Extraction Kits Market
8.14.3 Key Competitors of the Company
8.14.4 Analyst Perspective

List of Figures
Figure 1: Global Cell-Free RNA Isolation and Extraction Kits Market, $Million, 2021 and 2032
Figure 2: Global Cell-Free RNA Isolation and Extraction Kits Market Segmentation
Figure 3: Global Cell-Free RNA Isolation and Extraction Kits Market (by Application), $Million, 2021-2032
Figure 4: Global Cell-Free RNA Isolation and Extraction Kits Market (by End User), $Million, 2021-2032
Figure 5: Global Cell-Free RNA Isolation and Extraction Kits Market (by Region)
Figure 6: Global Cell-Free RNA Isolation and Extraction Kits Market Segmentation
Figure 7: Global Cell-Free RNA Isolation and Extraction Kits Market: Research Methodology
Figure 8: Primary Research Methodology
Figure 9: Bottom-Up Approach (Segment-Wise Analysis)
Figure 10: Top-Down Approach (Segment-Wise Analysis)
Figure 11: Global Cell-Free RNA Isolation and Extraction Kits Market, $Million, 2021-2032
Figure 12: Global Cell-Free RNA Isolation and Extraction Kits Market, Patent Analysis (by Year), January 2019-June 2022
Figure 13: Global Cell-Free RNA Isolation and Extraction Kits Market, Patent Analysis (by Country), January 2019-June 2022
Figure 14: Global Cell-Free RNA Isolation and Extraction Kits Market, Patent Analysis (by Region), January 2019-June 2022
Figure 15: FDA Classification for Medical Devices
Figure 16: Overview of Regulatory Process for Medical Devices in the U.S.
Figure 17: Overview of Regulatory Process in the European Union (EU)
Figure 18: Overview of Regulatory Process for Medical Devices in China
Figure 19: Global Cell-Free RNA Isolation and Extraction Kits Market Dynamics
Figure 20: Global Cancer Incidence, 2017-2021
Figure 21: Maternal Mortality Rate, Region-Wise, 2020
Figure 22: Maternal Mortality Rate in the U.S.
Figure 23: Ethical, Legal, and Social Issues
Figure 24: Funding Scenario in the Global Cell-Free RNA Isolation and Extraction Kits Market, $Million, January 2019-February 2022
Figure 25: Share of Key Developments, January 2019-February 2022
Figure 26: Share of Product Launches and Upgrades (by Company), January 2019-February 2022
Figure 27: Market Share Analysis of Global Cell-Free RNA Isolation and Extraction Kits Market (by Company), 2020 and 2021
Figure 28: Growth-Share Analysis for Global Cell-Free RNA Isolation and Extraction Kits Market (by Company), 2021
Figure 29: Global Cell-Free RNA Isolation and Extraction Kits Market (by Application), $Million, 2021-2032
Figure 30: Global Cell-Free RNA Isolation and Extraction Kits Market (Oncology), $Million, 2021-2032
Figure 31: Global Cell-Free RNA Isolation and Extraction Kits Market (Prenatal Screening), $Million, 2021-2032
Figure 32: Global Cell-Free RNA Isolation and Extraction Kits Market (Metabolic Disorders), $Million, 2021-2032
Figure 33: Global Cell-Free RNA Isolation and Extraction Kits Market (by End User), $Million, 2021-2032
Figure 34: Global Cell-Free RNA Isolation and Extraction Kits Market (Academic Research Institutions and Laboratories), 2021-2032
Figure 35: Global Cell-Free RNA Isolation and Extraction Kits Market (Hospitals), 2021-2032
Figure 36: Global Cell-Free RNA Isolation and Extraction Kits Market (Pharmaceutical and Biotechnology Companies), $Million, 2021-2032
Figure 37: Global Cell-Free RNA Isolation and Extraction Kits Market (Diagnostic Laboratories), $Million, 2021-2032
Figure 38: Global Cell-Free RNA Isolation and Extraction Kits Market (by Region)
Figure 39: Global Cell-Free RNA Isolation and Extraction Kits Market (by Region), 2021 and 2032
Figure 40: North America Cell-Free RNA Isolation and Extraction Kits Market, $Million, 2021-2032
Figure 41: Europe Cell-Free RNA Isolation and Extraction Kits Market, $Million, 2021-2032
Figure 42: Asia-Pacific Cell-Free RNA Isolation and Extraction kits Market, $Million, 2021-2032
Figure 43: Latin America Cell-Free RNA Isolation and Extraction Kits Market, $Million, 2021-2032
Figure 44: Rest-of-the-World Cell-Free RNA Isolation and Extraction kits Market, $Million, 2021-2032
Figure 45: Total Number of Companies Profiled
Figure 46: Aline Biosciences: Product Portfolio
Figure 47: Apostle Sciences: Product Portfolio
Figure 48: Danagen-Bioted, S.L.: Product Portfolio
Figure 49: F. Hoffmann-La Roche Ltd.: Product Portfolio
Figure 50: F. Hoffmann-La Roche Ltd.: Overall Financials, 2019-2021
Figure 51: F. Hoffmann-La Roche Ltd.: Revenue (by Segment), $Million, 2019-2021
Figure 52: F. Hoffmann-La Roche Ltd.: Revenue (by Region), $Million, 2019-2021
Figure 53: F. Hoffmann-La Roche Ltd.: R&D Expenditure, $Million, 2019-2021
Figure 54: JBS Science Inc.: Product Portfolio
Figure 55: Norgen Biotek Corp.: Product Portfolio
Figure 56: PerkinElmer, Inc.: Product Portfolio
Figure 57: PerkinElmer, Inc.: Overall Financials, $Million, 2019-2021
Figure 58: PerkinElmer, Inc.: Revenue (by Segment), $Million, 2019-2021
Figure 59: PerkinElmer, Inc.: Revenue (by Region), $Million, 2019-2021
Figure 60: PerkinElmer, Inc.: R&D Expenditure, $Million, 2019-2021
Figure 61: Promega Corporation: Product Portfolio
Figure 62: QIAGEN N.V.: Product Portfolio
Figure 63: QIAGEN N.V.: Overall Financials, $Million, 2019-2021
Figure 64: QIAGEN N.V.: Revenue (by Segment), $Million, 2019-2021
Figure 65: QIAGEN N.V.: Revenue (by Region), $Million, 2019-2021
Figure 66: QIAGEN N.V.: R&D Expenditure, $Million, 2019-2021
Figure 67: Streck, Inc.: Product Portfolio
Figure 68: Thermo Fisher Scientific Inc.: Product Portfolio
Figure 69: Thermo Fisher Scientific Inc.: Overall Financials, $Million, 2019-2021
Figure 70: Company Name: Revenue (by Segment), $Million, 2019-2021
Figure 71: Company Name: Revenue (by Region), $Million, 2019-2021
Figure 72: Thermo Fisher Scientific Inc.: R&D Expenditure, $Million, 2019-2021
Figure 73: Takara Bio Inc.: Product Portfolio
Figure 74: Takara Bio Inc.: Overall Financials, 2019-2022
Figure 75: Takara Bio Inc.: Revenue (by Segment), $Million, 2019-2022
Figure 76: Takara Bio Inc.: Revenue (by Region), $Million, 2019-2022
Figure 77: Takara Bio Inc.: R&D Expenditure, $Million, 2019-2022
Figure 78: Zymo Research Corporation: Product Portfolio

List of Tables
Table 1: Impact Analysis of Market Drivers, Restraints, and Opportunities on the Global Cell-Free RNA Isolation and Extraction Kits Market
Table 2: Different Types of Cell-Free RNA in Serum/Plasma
Table 3: Examples of Spin-Column Technology-Based Cell-Free RNA Isolation and Extraction Kits
Table 4: Examples of Magnetic-Bead Technology Based Cell-Free RNA Isolation and Extraction Kits
Table 5: Likert Scale
Table 6: Impact Analysis of Market Drivers, Restraints, and Opportunities on the Global Cell-Free RNA Isolation and Extraction Kits Market

Companies Mentioned

  • Aline Biosciences
  • Apostle Sciences
  • Danagen-Bioted, S.L.
  • F. Hoffmann-La Roche Ltd.
  • JBS Science Inc.
  • Norgen Biotek Corp.
  • PerkinElmer, Inc.
  • Promega Corporation
  • QIAGEN N.V.
  • Streck, Inc.
  • Thermo Fisher Scientific Inc.
  • Takara Bio Inc.
  • Zymo Research Corporation